Loading insider details...
Beta
Latest Form 4 (Aug 29, 2026): Sale of 185,000 PGEN shares, $1.38M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 29, 2026 | PRECIGEN, INC. (PGEN) | Sale | 185,000 | $1.38M |
| Jun 12, 2026 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 1,371 | n/a |
| May 5, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Disposition to Issuer | 32,000 | n/a |
| Mar 16, 2026 | PRECIGEN, INC. (PGEN) | Exercise/Conversion | 71,839 | n/a |
| Mar 12, 2026 | PRECIGEN, INC. (PGEN) | Grant/Award | 19,658 | $69.0K |
| Feb 10, 2026 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 688 | n/a |
| Feb 2, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 1,697 | n/a |
| Dec 16, 2025 | PRECIGEN, INC. (PGEN) | Sale | 235,467 | $855.9K |
| Oct 1, 2025 | PRECIGEN, INC. (PGEN) | Sale | 67,523 | $243.1K |
| Jun 12, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 45,000 | n/a |